What Is Cellyan Biotechnology Co., Ltd (HKPD) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, the balance of valuation evidence tilts cautious on Cellyan Biotechnology Co., Ltd at its current price of $0.43. The composite intrinsic value is estimated at $0.33 (-23.0% average return), with 7 models flagging overvaluation risk. Notably, ML-RIV sees the most upside at +42.2% (fair value: $0.61), while EPV is the most conservative at -93.4% ($0.03). The spread between these extremes — +135.6% — reveals how different analytical frameworks can reach starkly different conclusions.
What Do the Models Say About HKPD?
12 of 13 models are currently active for HKPD. Of these, 4 models suggest upside while 8 models suggest overvaluation. The Bayesian DCF estimates HKPD's intrinsic value at $0.10, implying -75.7% downside from the current price. See which stocks rank higher →
How Does HKPD Rank in Wholesale-Drugs, Proprietaries & Druggists' Sundries?
Among 10 Wholesale-Drugs, Proprietaries & Druggists' Sundries stocks, HKPD ranks #10 by Quality of Company score. CirclFi's QOC score of 2.0/10 evaluates 32 fundamental signals. A score of 2.0 signals below-average fundamentals.
As a healthcare company, Cellyan Biotechnology Co., Ltd operates in a sector where biosimilar competition timeline is a critical driver of valuation. Investors evaluating HKPD should weigh these sector-specific dynamics alongside our model-derived fair values.
Is HKPD a Value Trap?
The Value Trap algorithm is not active for HKPD. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
12 of 13 models are active for Cellyan Biotechnology Co., Ltd. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi 32-factor quality framework, Cellyan Biotechnology Co., Ltd's fundamental quality profile registers 2.0/10. This concerning score captures the company's profitability depth, growth consistency, balance sheet resilience, and shareholder return track record.
The gap between the most bullish and bearish model spans +135.6% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every HKPD valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across HKPD's 12 active models, average confidence is 11%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad